ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660439 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660439; 2) Community: the network communities that were significantly associated with the response to NSC 660439; 3) Molecule: the relationships between components within communities and NSC 660439; 4) MDR: the compounds that were significantly associated with the NSC 660439.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0273071169565318 0.1561086
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.0273071169565318 0.18515224
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.0273071169565318 0.51312396
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0273071169565318 0.061340175
NSC 355461 B621099K443 0.0273071169565318 0.31254691
NSC 374028 Camptothecin Derivative 0.0273071169565318 0.24293232
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0273071169565318 0.39908328
NSC 606498 Camptothecin Derivative 0.0273071169565318 0.075939423
NSC 625500 Null 0.0273071169565318 -0.092109749
NSC 643419 Null 0.0273071169565318 -0.076379537
Total:34  Current:17    [First] [Prev] [Next] [Last]